260 related articles for article (PubMed ID: 23981342)
1. Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.
Shen Y; Ma X; Zhou J; Pan X; Hao Y; Zhou M; Lu Z; Gao M; Bao Y; Jia W
Cardiovasc Diabetol; 2013 Aug; 12():124. PubMed ID: 23981342
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23 is associated with the presence of coronary artery disease and the number of stenotic vessels.
Hu X; Ma X; Pan X; Hao Y; Luo Y; Lu Z; Bao Y; Jia W
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1152-7. PubMed ID: 26217893
[TBL] [Abstract][Full Text] [Related]
3. High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China.
Li H; Dong K; Fang Q; Hou X; Zhou M; Bao Y; Xiang K; Xu A; Jia W
J Hepatol; 2013 Mar; 58(3):557-63. PubMed ID: 23142063
[TBL] [Abstract][Full Text] [Related]
4. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
[TBL] [Abstract][Full Text] [Related]
5. Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.
Ballestri S; Meschiari E; Baldelli E; Musumeci FE; Romagnoli D; Trenti T; Zennaro RG; Lonardo A; Loria P
Metab Syndr Relat Disord; 2013 Aug; 11(4):289-95. PubMed ID: 23600632
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.
Hou XH; Zhu YX; Lu HJ; Chen HF; Li Q; Jiang S; Xiang KS; Jia WP
J Gastroenterol Hepatol; 2011 Apr; 26(4):722-30. PubMed ID: 21418302
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.
Thakur ML; Sharma S; Kumar A; Bhatt SP; Luthra K; Guleria R; Pandey RM; Vikram NK
Atherosclerosis; 2012 Aug; 223(2):507-11. PubMed ID: 22748277
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events.
Wu L; Qian L; Zhang L; Zhang J; Zhou J; Li Y; Hou X; Fang Q; Li H; Jia W
J Am Heart Assoc; 2020 Jun; 9(11):e015226. PubMed ID: 32431189
[TBL] [Abstract][Full Text] [Related]
9. Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients.
Zhang X; Hu Y; Zeng H; Li L; Zhao J; Zhao J; Liu F; Bao Y; Jia W
Cardiovasc Diabetol; 2015 Mar; 14():32. PubMed ID: 25850006
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans.
Choi DH; Lee SJ; Kang CD; Park MO; Choi DW; Kim TS; Lee W; Cho BR; Kim YH; Lee BK; Ryu DR; Lee JW
World J Gastroenterol; 2013 Oct; 19(38):6453-7. PubMed ID: 24151364
[TBL] [Abstract][Full Text] [Related]
11. Fatty liver index correlates with non-alcoholic fatty liver disease, but not with newly diagnosed coronary artery atherosclerotic disease in Chinese patients.
Jiang ZY; Xu CY; Chang XX; Li WW; Sun LY; Yang XB; Yu LF
BMC Gastroenterol; 2013 Jul; 13():110. PubMed ID: 23834773
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus.
He X; Hu X; Ma X; Su H; Ying L; Peng J; Pan X; Bao Y; Zhou J; Jia W
Cardiovasc Diabetol; 2017 Jun; 16(1):77. PubMed ID: 28619026
[TBL] [Abstract][Full Text] [Related]
13. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
Al Rifai M; Silverman MG; Nasir K; Budoff MJ; Blankstein R; Szklo M; Katz R; Blumenthal RS; Blaha MJ
Atherosclerosis; 2015 Apr; 239(2):629-33. PubMed ID: 25683387
[TBL] [Abstract][Full Text] [Related]
14. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
15. Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome.
Ni J; Ma X; Zhou M; Pan X; Tang J; Hao Y; Lu Z; Gao M; Bao Y; Jia W
Cardiovasc Diabetol; 2013 Dec; 12():176. PubMed ID: 24359145
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese.
Huang Y; Bi Y; Xu M; Ma Z; Xu Y; Wang T; Li M; Liu Y; Lu J; Chen Y; Huang F; Xu B; Zhang J; Wang W; Li X; Ning G
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2321-6. PubMed ID: 22814750
[TBL] [Abstract][Full Text] [Related]
17. The single nucleotide polymorphism rs499765 is associated with fibroblast growth factor 21 and nonalcoholic fatty liver disease in a Chinese population with normal glucose tolerance.
Jiang S; Zhang R; Li H; Fang Q; Jiang F; Hou X; Hu C; Jia W
J Nutrigenet Nutrigenomics; 2014; 7(3):121-9. PubMed ID: 25359230
[TBL] [Abstract][Full Text] [Related]
18. High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease.
Yang W; Huang H; Wang Y; Yu X; Yang Z
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):174-8. PubMed ID: 24025980
[TBL] [Abstract][Full Text] [Related]
19. Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis.
Ong KL; McClelland RL; Allison MA; Kokkinos J; Wu BJ; Barter PJ; Rye KA
Atherosclerosis; 2019 Feb; 281():200-206. PubMed ID: 30446181
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.
Li H; Fang Q; Gao F; Fan J; Zhou J; Wang X; Zhang H; Pan X; Bao Y; Xiang K; Xu A; Jia W
J Hepatol; 2010 Nov; 53(5):934-40. PubMed ID: 20675007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
